The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

CLIN CLINIGEN GROUP PLC ORD 0.1P




 Page 2 of 6

Previous | 1 | 2 | 3 | 4 | 5 | 6 | Next

Time/Date Code Headline Source Impact
10:39 03-Oct-2017 CLIN Director/PDMR Shareholding RNS +5.47% Up
10:10 03-Oct-2017 CLIN FORM 8 (DD) - Clinigen Group plc RNS +5.47% Up
11:20 29-Sep-2017 CLIN Rule 2.9 Announcement RNS +4.79% Up
09:15 29-Sep-2017 CLIN Issue of Equity RNS +4.79% Up
16:44 28-Sep-2017 CLIN Form 8.3 - Clinigen Group plc BZN +4.29% Up
07:00 28-Sep-2017 CLIN Final Results RNS +4.29% Up
15:00 26-Sep-2017 CLIN Form 8.3 - Clinigen Group PLC BZN +4.33% Up
15:00 25-Sep-2017 CLIN Form 8.3 - Clinigen Group PLC BZN +4.14% Up
14:00 25-Sep-2017 CLIN Clinigen and Cumberland launch Totect® in the U.S. RNS +4.14% Up
16:05 22-Sep-2017 CLIN Form 8.3 - Clinigen Group plc BZN +4.73% Up
15:00 22-Sep-2017 CLIN Form 8.3 - Clinigen Group PLC BZN +4.73% Up
10:07 20-Sep-2017 CLIN Rule 2.9 Announcement RNS +2.45% Up
14:49 19-Sep-2017 CLIN Issue of Equity RNS -0.68% Down
14:35 18-Sep-2017 CLIN Form 8.3 - Clinigen Group Plc BZN -2.90% Down
14:45 15-Sep-2017 CLIN Form 8.3 - Clinigen Group Plc BZN -5.13% Down
15:54 14-Sep-2017 CLIN Form 8.3 - Clinigen Group Plc BZN -6.42% Down
07:00 13-Sep-2017 CLIN Recommended Offer for Quantum Pharma plc RNS -7.05% Down
07:00 13-Sep-2017 CLIN Form 8.3 - Clinigen Group Plc BZN -7.05% Down
07:00 12-Sep-2017 CLIN Form 8.3 - Clinigen Group Plc BZN -5.85% Down
11:00 11-Sep-2017 CLIN Rule 2.9 Announcement RNS -5.02% Down

 Page 2 of 6

Previous | 1 | 2 | 3 | 4 | 5 | 6 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.





Company Information
Updated Monthly
Company address Pitcairn House, Crown Square, Centrum 100, Burton-on-Trent, DE14 2WW, United Kingdom
Company website http://www.clinigengrou...
Market cap(in millions)* £ 1,295.96
Listing/Admission to trading 25 Sep 2012
Trading service SETS
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
21-Oct-17
FTSE index FTSE AIM All-Share,FTSE AIM 100,FTSE AIM UK 50,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment AMSM
MiFID Status MTF
Exchange market size 2,000
SEDOL B89J241
ISIN number GB00B89J2419



CLINIGEN share news analysis (CLIN)